Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: The HPA axis, BDNF expression and phosphorylation of ERK

Pharmacology Biochemistry and Behavior

Volumn 112, Issue , 2013, Pages 104-110

  Wang, Zhen ^a   Gu, Jianhua ^a   Wang, Xueer ^a,b   Xie, Kai ^a   Luan, Qinsong ^a   Wan, Nianqing ^a   Zhang, Qun ^a   Jiang, Hong ^a   Liu, Dexiang ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LUOYANG NORMAL UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factor (BDNF); Extracellular signal regulated kinase (ERK); Forced swim test; Resveratrol; Tail suspension test; The hypothalamic pituitary adrenal axis

Indexed keywords

BETA ACTIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; FLUOXETINE; MITOGEN ACTIVATED PROTEIN KINASE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DRUG DOSE REDUCTION; ENZYME PHOSPHORYLATION; EXPERIMENTAL TEST; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TAIL SUSPENSION TEST;

MUS; POLYGONUM CUSPIDATUM;

BDNF; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF); ERK; EXTRACELLULAR SIGNAL-REGULATED KINASE; EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK); FORCED SWIM TEST; FST; HPA; HYPOTHALAMIC-PITUITARY-ADRENAL; PFC; PREFRONTAL CORTEX; RESVERATROL; REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; RT-PCR; TAIL SUSPENSION TEST; THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS; TST;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HINDLIMB SUSPENSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; PHOSPHORYLATION; PITUITARY-ADRENAL SYSTEM; STILBENES; STRESS, PHYSIOLOGICAL; SWIMMING;

EID: 84887103262     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.10.007     Document Type: Article

References (37)

1. D. Albani, L. Polito, S. Batelli, S. De Mauro, C. Fracasso, and G. Martelli The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide J Neurochem 110 2009 1445 1456
2. E. Castren, V. Voikar, and T. Rantamaki Role of neurotrophic factors in depression Curr Opin Pharmacol 7 2007 18 21 (Pubitemid 46238033)
3. B. Chen, D. Dowlatshahi, G.M. MacQueen, J.F. Wang, and L.T. Young Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication Biol Psychiatry 50 2001 260 265 (Pubitemid 32778442)
4. Y. Chen, L.D. Kong, X. Xia, H.F. Kung, and L. Zhang Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the forced swimming test in mice J Ethnopharmacol 96 2005 451 459 (Pubitemid 41556595)
5. T.J. Connor, J.P. Kelly, and B.E. Leonard Forced swim test-induced neurochemical endocrine, and immune changes in the rat Pharmacol Biochem Behav 58 1997 961 967 (Pubitemid 28108203)
6. T.J. Connor, P. Kelliher, A. Harkin, J.P. Kelly, and B.E. Leonard Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat Euro J Pharmacol 379 1999 125 133
7. T.J. Connor, P. Kelliher, Y. Shen, A. Harkin, J.P. Kelly, and B.E. Leonard Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test Pharmacol Biochem Behav 65 2000 591 597 (Pubitemid 30182501)
8. J.F. Cryan, C. Mombereau, and A. Vassout The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice Neurosci Biobehav Rev 29 2005 571 625 (Pubitemid 40755457)
9. T.G. Dinan Glucocorticoids and the genesis of depressive illness. A psychobiological model Br J Psychiatry 164 1994 365 371 (Pubitemid 24095296)
10. R.S. Duman, and L.M. Monteggia A neurotrophic model for stress-related mood disorders Biol Psychiatry 59 2006 1116 1127
11. H. Einat, P. Yuan, T.D. Gould, J. Li, J. Du, and L. Zhang The role of the extracellular signal-regulated kinase signaling pathway in mood modulation J Neurosci 23 2003 7311 7316 (Pubitemid 36999520)
12. M. First, I. Gil-Ad, M. Taler, I. Tarasenko, N. Novak, and A. Weizman The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression J Mol Neurosci 45 2011 246 255
13. J.P. Guilloux, G. Douillard-Guilloux, R. Kota, X. Wang, A.M. Gardier, and K. Martinowich Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression Mol Psychiatry 17 2012 1130 1142
14. B.H. Han, and D.M. Holtzman BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway J Neurosci 20 2000 5775 5781 (Pubitemid 30636906)
15. E.J. Huang, and L.F. Reichardt Neurotrophins: roles in neuronal development and function Annu Rev Neurosci 24 2001 677 736 (Pubitemid 32695243)
16. J.H. Jang, and Y.J. Surh Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death Free Radic Biol Med 34 2003 1100 1110
17. F. Karege, G. Bondolfi, N. Gervasoni, M. Schwald, J.M. Aubry, and G. Bertschy Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity Biol Psychiatry 57 2005 1068 1072 (Pubitemid 40613035)
18. R.C. Kessler The costs of depression Psychiatr Clin North Am 35 2012 1 14
19. H.K. Manji, W.C. Drevets, and D.S. Charney The cellular neurobiology of depression Nat Med 7 2001 541 547 (Pubitemid 32448319)
20. Y. Mebratu, and Y. Tesfaigzi How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle 8 2009 1168 1175
21. P. Orsu, B.V. Murthy, and A. Akula Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats J Neural Transm 120 8 2013 1217 1223
22. J. Ortiz, H.W. Harris, X. Guitart, R.Z. Terwilliger, J.W. Haycock, and E.J. Nestler Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine J Neurosci 15 1995 1285 1297
23. X. Qi, W. Lin, J. Li, H. Li, W. Wang, and D. Wang Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress Neurobiol Dis 31 2008 278 285
24. T. Rantamaki, J.E. Knuuttila, M.E. Hokkanen, and E. Castren The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex Neuropharmacology 50 2006 421 427 (Pubitemid 43209038)
25. A.A. Russo-Neustadt, R.C. Beard, Y.M. Huang, and C.W. Cotman Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus Neuroscience 101 2000 305 312
26. Y. Shirayama, A.C. Chen, S. Nakagawa, D.S. Russell, and R.S. Duman Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression J Neurosci 22 2002 3251 3261 (Pubitemid 35379212)
27. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 1985 367 370 (Pubitemid 15123115)
28. A.Y. Sun, Y.M. Chen, M. James-Kracke, P. Wixom, and Y. Cheng Ethanol-induced cell death by lipid peroxidation in PC12 cells Neurochem Res 22 1997 1187 1192 (Pubitemid 27440785)
29. A.F. Thachil, R. Mohan, and D. Bhugra The evidence base of complementary and alternative therapies in depression J Affect Disord 97 2007 23 35 (Pubitemid 44963511)
30. E. Tiraboschi, D. Tardito, J. Kasahara, S. Moraschi, P. Pruneri, and M. Gennarelli Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades Neuropsychopharmacology 29 2004 1831 1840 (Pubitemid 39336795)
31. V. Tiwari, and K. Chopra Resveratrol abrogates alcohol-induced cognitive deficits by attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat brain Neurochem Int 62 2013 861 869
32. J. Wang, L. Ho, Z. Zhao, I. Seror, N. Humala, and D.L. Dickstein Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease FASEB J 20 2006 2313 2320 (Pubitemid 44953861)
33. Y. Xu, Z. Wang, W. You, X. Zhang, S. Li, and P.A. Barish Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system Eur Neuropsychopharmacol 20 2010 405 413
34. Y. Yu, R. Wang, C. Chen, X. Du, L. Ruan, and J. Sun Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences J Psychiatr Res 47 2013 315 322
35. F. Zhang, J. Liu, and J.S. Shi Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation Eur J Pharmacol 636 2010 1 7
36. L. Zhang, T. Xu, S. Wang, L. Yu, D. Liu, and R. Zhan Curcumin produces antidepressant effects via activating MAPK/ERK-dependent brain-derived neurotrophic factor expression in the amygdala of mice Behav Brain Res 235 2012 67 72
37. H. Zhuang, Y.S. Kim, R.C. Koehler, and S. Dore Potential mechanism by which resveratrol, a red wine constituent, protects neurons Ann N Y Acad Sci 993 2003 276 286 [discussion 287-278] (Pubitemid 36808455)